Recursion Pharmaceuticals Inc Cl A (RXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||
| Net Income | -37,367 | -18,424 | -61,879 |
| Depreciation Amortization | 1,961 | 937 | 3,044 |
| Accounts receivable | 142 | 82 | N/A |
| Accounts payable and accrued liabilities | 92 | 625 | N/A |
| Other Working Capital | -1,000 | -1,617 | 408 |
| Other Operating Activity | 1,656 | 580 | 1,385 |
| Operating Cash Flow | $-34,516 | $-17,817 | $-57,042 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -1,318 | -684 | -3,910 |
| Purchase Of Investment | 595 | N/A | N/A |
| Investing Cash Flow | $-723 | $-684 | $-3,910 |
| Cash Flows From Financing Activities | |||
| Debt Issued | 6,400 | 6,000 | N/A |
| Debt Repayment | -37 | -19 | N/A |
| Common Stock Issued | 16 | 16 | N/A |
| Other Financing Activity | 0 | 0 | 120,410 |
| Financing Cash Flow | $6,379 | $5,997 | $120,410 |
| Beginning Cash Position | 75,171 | 75,171 | 15,713 |
| End Cash Position | 46,311 | 62,667 | 75,171 |
| Net Cash Flow | $-28,860 | $-12,504 | $59,458 |
| Free Cash Flow | |||
| Operating Cash Flow | -34,516 | -17,817 | -57,042 |
| Capital Expenditure | -1,318 | -684 | N/A |
| Free Cash Flow | -35,834 | -18,501 | -57,042 |